CUSIP: 36118A100
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,173,365
-
Share change
-
+28,171,565
-
Total reported value
-
$482,962,368
-
Price per share
-
$17.47
-
Number of holders
-
51
-
Value change
-
+$482,931,368
-
Number of buys
-
50
Quarterly Holders Quick Answers
What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 36118A100:
Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q2 2020
As of 30 Jun 2020,
FUSION PHARMACEUTICALS INC - COM (FUSN) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,173,365 shares.
The largest 10 holders included
Johnson & Johnson Innovation - JJDC, Inc., ADAMS STREET PARTNERS LLC, ORBIMED ADVISORS LLC, CANADA PENSION PLAN INVESTMENT BOARD, FMR LLC, TPG Group Holdings (SBS) Advisors, Inc., PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rock Springs Capital Management LP, and MORGAN STANLEY.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.